| mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.26 |
5e-14 |
| mRNA |
AC220 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
3e-10 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
8e-07 |
| mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
1e-06 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
4e-06 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-06 |
| mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
6e-06 |
| mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
2e-05 |
| mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
3e-05 |